 systemic review evaluating VD following sclerotherapy of varicose veins, reticular
veins and telangiectasias. While the prevalence of VD was
difï¬cult to determine, two RCTs reported no VDs (95 and
75 patients treated, respectively). In large case series
(>500 patients), the prevalence of VD ranged from
0.09% to 2%. In a meta-analysis that included over 90